Brain Diseases


160 genes linked to brain shrinkage in study of 45,000 adults

September 25, 2020
 

Comparison of genes and MRI results shows associations A new study implicates 160 genes in brain shrinkage seen on MRIs of 45,000 healthy adults. The shrinkage is in the cortex, the dimply outer layer of the brain that gives rise to thinking, awareness and action, and largely consists of gray matter. The study, published Sept. […]



KSAT 12: Long-awaited new ALS drug shows promise at UT Health San Antonio

September 14, 2020
 

Dr. Carlayne Jackson, professor of neurology and otolaryngology, co-authored a new study that includes the results of a small clinical trial for an oral drug that slowed ALS patients’ rate of functional decline. Read and watch the story.



Physician develops device to relieve hiccups

September 11, 2020
 

A neuro-intensive care physician at UT Health San Antonio has invented a science-based way to stop hiccups. The device is called HiccAway.




Oral pill slows rate of decline in ALS patients

September 10, 2020
 

If the finding is repeated in larger trials, the drug could give families more time with their loved ones who have ALS.



Prescription pills and bottle

Oral pill slows rate of decline in ALS patients

September 8, 2020
 

Although it’s not a cure for ALS, an oral drug slowed patients’ rate of functional decline in a clinical trial that included five patients at UT Health San Antonio. If the finding is repeated in larger trials, the drug could give families more time with their loved ones who have ALS. The New England Journal […]




$2M grant awarded to study drug’s impact on Alzheimer’s patients

August 25, 2020
 

In the war on cancer and other diseases including COVID-19, old drugs approved for other conditions are being studied for new purposes. It’s a strategy that will now be tested in Alzheimer’s disease with a drug called rapamycin. A $2 million grant will enable a clinical trial in which 40 individuals with mild cognitive impairment […]